The Enso Study for Chronic Low Back Pain

Inclusion Criteria:

1. Mechanical (myofascial), axial back pain (focused around the spine)

2. 6/10 or greater level of pain

3. Functionally debilitated by their pain (e.g., difficulty walking)

4. Minimal radicular symptoms with no effect on functionality, medication, quality oflife

5. Expressed desire to stop taking pain medications

6. Expressed desire to improve disability

7. 80% or greater of disability is due to pain in the low back (as opposed to other bodyareas)

8. Experiencing chronic pain for at least 6 months

9. Interested in being active, improving their functionality

10. Comfortable with using technology in daily life

11. Subject able to understand and grant informed consent

12. Documented adherence with clinic follow up visits per medical records

13. Has an email account

14. Above 18 years old

Exclusion Criteria:

1. Patients that do not own or have access to a smartphone

2. Has spinal instability, joint instability, or grade 2 or greater spondylolisthesiswith instability

3. Primary symptoms due to spinal stenosis

4. Source of back pain related to an acute nerve impingement

5. Diagnosis of cancer/malignant tumors in the last 5 years

6. Source of back pain is an infection

7. Source of pain is a prior spinal fusion surgery

8. Has a cardiac pacemaker, implanted defibrillator or other implanted electronic device

9. Has radicular pain symptoms that affect functionality, quality of life or medicationintake

10. Has undergone surgery to solve pain related to the study indication in the past 6months

11. Patients with history of opioid, alcohol or drug abuse in the last 5 years, perinvestigator discretion

12. Any psychiatric condition that may interfere with the study assessments or prevent thesubject from complying with the requirements of the protocol, in the judgement of theinvestigator

13. Inability to complete subjective data as required; e.g. on mobile application andquestionnaires

14. Pregnant women (as determined by self-report)

15. Have severe epilepsy

16. Have severe form of cardiovascular disease

17. Any other disease, condition, or habit(s) that in the opinion of the PrincipalInvestigator would interfere with study compliance or adversely affect study outcomes